News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
ShapeTX Enhances Collaboration with Roche Through Introduction of a Novel Therapeutic Target
Friday, December 01, 2023ShapeTX announced today an expansion of its partnership with Roche with Roche introducing a new target to their ongoing collaboration initially established in August This expansion
Inipharm Initiates Dosing in Phase 1 Trial for Small Molecule Inhibitor Targeting HSD17B13
Friday, December 01, 2023Inipharm a biopharmaceutical company focused on developing therapies for severe liver diseases has announced the initiation of dosing in a Phase study for INI its orallydelivered small molecule inhibitor of HSDB
OncoResponse Initiates Phase 1/2 Clinical Trial for OR502, an Anti-LILRB2 Antibody, in Patients with Advanced Cancer
Thursday, November 30, 2023OncoResponse a clinicalstage biotech company specializing in immunotherapies derived from the immune systems of Elite Cancer Responders has recently initiated the Phase trial for OR
Phenomic and Boehringer Ingelheim Establish Strategic Collaboration for the Discovery of Novel Targets in Stroma-Enriched Cancer Therapies
Thursday, November 30, 2023Phenomic AI has recently announced a strategic collaboration and licensing agreement with Boehringer Ingelheim focusing on the identification of targets crucial in stromarich cancers The collaboration
Roslinct and Vertex Pharmaceuticals Inc to Collaborate on Manufacturing Exagamglogene Autotemcel (Exa-cel) Following Extensive Development Partnership
Wednesday, November 29, 2023RoslinCT a Contract Development and Manufacturing Organization specializing in cell and gene therapy has announced its involvement in manufacturing the worlds first CRISPRbased therapy
Ethris Secures Approval for Phase I Clinical Trial of ETH47, an Innovative Inhaled mRNA Solution for Respiratory Viral Infections
Wednesday, November 29, 2023Ethris GmbH a leading biotechnology company focused on advancing nextgeneration RNA therapeutics and vaccines has secured approval from the United Kingdom Medicines and Healthcare products
FDA Grants Approval for Initial Treatment of Rare Non-Cancerous Tumors
Tuesday, November 28, 2023Today the US Food and Drug Administration has granted approval for Ogsiveo nirogacestat tablets marking a significant milestone as the first drug sanctioned for the treatment
TC BioPharm Receives FDA Clearance for Phase 1B Investigational New Drug (IND) TCB-008 in Acute Myeloid Leukemia
Tuesday, November 28, 2023TC BioPharm PLC a biotechnology company focused on developing allogeneic gammadelta T cell therapies for cancer has received clearance from the FDA
Medivir Introduces an Improved Formulation of Fostrox, Essential for Facilitating a Planned Study Aimed at Accelerated Approval in the Second-line Treatment of Hepatocellular Carcinoma
Monday, November 27, 2023Medivir AB recently reported the successful completion of the development of an updated formulation of fostrox intended for commercial manufacturing Fostrox created by the pharmaceutical company
FDA Grants Orphan Drug Designation to Mocravimod for Allogeneic HSCT in Hematologic Malignancies - Priothera
Monday, November 27, 2023Priothera Ltd has announced that the US Food and Drug Administration granted Orphan Drug designation to its compound mocravimod a SP receptor modulator This designation is for the treatment aimed
